Epstein-Barr Virus-Positive Cancers Show Altered B-Cell Clonality

Sara R Selitsky; David Marron; Lisle E Mose; Joel S Parker; Dirk P Dittmer

doi:10.1128/mSystems.00081-18

Epstein-Barr Virus-Positive Cancers Show Altered B-Cell Clonality

mSystems. 2018 Sep 25;3(5):e00081-18. doi: 10.1128/mSystems.00081-18. eCollection 2018 Sep-Oct.

Authors

Sara R Selitsky¹, David Marron¹, Lisle E Mose¹, Joel S Parker^{1

2}, Dirk P Dittmer^{1

3}

Affiliations

¹ Lineberger Comprehensive Cancer Center, School of Medicine at the University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
² Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
³ Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

Abstract

Epstein-Barr virus (EBV) is convincingly associated with gastric cancer, nasopharyngeal carcinoma, and certain lymphomas, but its role in other cancer types remains controversial. To test the hypothesis that there are additional cancer types with high prevalence of EBV, we determined EBV viral expression in all the Cancer Genome Atlas Project (TCGA) mRNA sequencing (mRNA-seq) samples (n = 10,396) from 32 different tumor types. We found that EBV was present in gastric adenocarcinoma and lymphoma, as expected, and was also present in >5% of samples in 10 additional tumor types. For most samples, EBV transcript levels were low, which suggests that EBV was likely present due to infected infiltrating B cells. In order to determine if there was a difference in the B-cell populations, we assembled B-cell receptors for each sample and found B-cell receptor abundance (P ≤ 1.4 × 10^-20) and diversity (P ≤ 8.3 × 10^-27) were significantly higher in EBV-positive samples. Moreover, diversity was independent of B-cell abundance, suggesting that the presence of EBV was associated with an increased and altered B-cell population. IMPORTANCE Around 20% of human cancers are associated with viruses. Epstein-Barr virus (EBV) contributes to gastric cancer, nasopharyngeal carcinoma, and certain lymphomas, but its role in other cancer types remains controversial. We assessed the prevalence of EBV in RNA-seq from 32 tumor types in the Cancer Genome Atlas Project (TCGA) and found EBV to be present in >5% of samples in 12 tumor types. EBV infects epithelial cells and B cells and in B cells causes proliferation. We hypothesized that the low expression of EBV in most of the tumor types was due to infiltration of B cells into the tumor. The increase in B-cell abundance and diversity in subjects where EBV was detected in the tumors strengthens this hypothesis. Overall, we found that EBV was associated with an increased and altered immune response. This result is not evidence of causality, but a potential novel biomarker for tumor immune status.

Keywords: B cells; EBV; Epstein-Barr virus; TCGA; cancer; herpesvirus; virology.

Abstract

Grants and funding